Chemoinformaics analysis of BENZYLADENINE-7-O-BETA-D-GLUCOSIDE
Molecular Weight | 387.396 | nRot | 5 |
Heavy Atom Molecular Weight | 366.228 | nRig | 23 |
Exact Molecular Weight | 387.154 | nRing | 4 |
Solubility: LogS | -2.188 | nHRing | 3 |
Solubility: LogP | -0.375 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 49 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 28 | No. of Aromatic Carbocycles | 1 |
nHetero | 10 | No. of Aromatic Hetero Cycles | 2 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 21 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 18 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 5 | No. of Arom Atom | 15 |
No. of Oxygen atom | 5 | No. of Arom Bond | 16 |
nHA | 10 | APOL | 53.5727 |
nHD | 5 | BPOL | 28.5033 |
QED | 0.379 |
Synth | 4.262 |
Natural Product Likeliness | 0.76 |
NR-PPAR-gamma | 0.013 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.754 |
HIA | 0.987 |
CACO-2 | -5.67 |
MDCK | 0.00000586 |
BBB | 0.774 |
PPB | 0.27749 |
VDSS | 2.776 |
FU | 0.658991 |
CYP1A2-inh | 0.027 |
CYP1A2-sub | 0.186 |
CYP2c19-inh | 0.018 |
CYP2c19-sub | 0.064 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.161 |
CYP2d6-inh | 0.011 |
CYP2d6-sub | 0.054 |
CYP3a4-inh | 0.029 |
CYP3a4-sub | 0.073 |
CL | 7.808 |
T12 | 0.687 |
hERG | 0.053 |
Ames | 0.084 |
ROA | 0.388 |
SkinSen | 0.062 |
Carcinogencity | 0.043 |
EI | 0.007 |
Respiratory | 0.924 |
NR-Aromatase | 0.937 |
Antiviral | Yes |
Prediction | 0.895026 |